Choline intake in a large cohort of patients with nonalcoholic fatty liver disease
- PMID: 22338037
- PMCID: PMC3302364
- DOI: 10.3945/ajcn.111.020156
Choline intake in a large cohort of patients with nonalcoholic fatty liver disease
Abstract
Background: There is significant histologic and biochemical overlap between nonalcoholic fatty liver disease (NAFLD) and steatohepatitis associated with choline deficiency.
Objective: We sought to determine whether subjects with biopsy-proven NAFLD and evidence of an inadequate intake of choline had more severe histologic features.
Design: We performed a cross-sectional analysis of 664 subjects enrolled in the multicenter, prospective Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) with baseline data on diet composition (from a recall-based food-frequency questionnaire) within 6 mo of a liver biopsy. Food questionnaires were analyzed with proprietary software to estimate daily intakes of choline. Liver biopsies were centrally read, and consensus was scored with the NASH CRN-developed scoring system. Because choline needs vary by age, sex, and menopausal status, participants were segregated into corresponding categories (children 9-13 y old, males ≥14 y old, premenopausal women ≥19 y old, and postmenopausal women) on the basis of the Institute of Medicine's definition of adequate intake (AI) for choline. Deficient intake was defined as <50% AI.
Results: Postmenopausal women with deficient choline intake had worse fibrosis (P = 0.002) once factors associated with NAFLD (age, race-ethnicity, obesity, elevated triglycerides, diabetes, alcohol use, and steroid use) were considered in multiple ordinal logistic regression models. Choline intake was not identified as a contributor to disease severity in children, men, or premenopausal women.
Conclusion: Decreased choline intake is significantly associated with increased fibrosis in postmenopausal women with NAFLD. The Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis trial was registered at clinicaltrials.gov as NCT00063622, and the Treatment of Nonalcoholic Fatty Liver Disease in Children trial was registered at clinicaltrials.gov as NCT00063635.
Similar articles
-
Histopathology, grading and staging of nonalcoholic fatty liver disease.Minerva Gastroenterol Dietol. 2018 Mar;64(1):28-38. doi: 10.23736/S1121-421X.17.02445-X. Epub 2017 Sep 25. Minerva Gastroenterol Dietol. 2018. PMID: 28948754 Review.
-
Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children.Clin Liver Dis. 2016 May;20(2):293-312. doi: 10.1016/j.cld.2015.10.011. Epub 2015 Dec 28. Clin Liver Dis. 2016. PMID: 27063270 Free PMC article. Review.
-
Higher dietary choline intake is associated with lower risk of nonalcoholic fatty liver in normal-weight Chinese women.J Nutr. 2014 Dec;144(12):2034-40. doi: 10.3945/jn.114.197533. Epub 2014 Oct 15. J Nutr. 2014. PMID: 25320186 Free PMC article.
-
Estimation of fish and ω-3 fatty acid intake in pediatric nonalcoholic fatty liver disease.J Pediatr Gastroenterol Nutr. 2013 Nov;57(5):627-33. doi: 10.1097/MPG.0b013e3182a1df77. J Pediatr Gastroenterol Nutr. 2013. PMID: 24177784 Free PMC article. Clinical Trial.
-
Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD.J Pediatr Gastroenterol Nutr. 2012 Jan;54(1):90-6. doi: 10.1097/MPG.0b013e318229da1a. J Pediatr Gastroenterol Nutr. 2012. PMID: 22197855 Free PMC article.
Cited by
-
NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic-Metabolic Interplay.Life (Basel). 2024 Feb 18;14(2):272. doi: 10.3390/life14020272. Life (Basel). 2024. PMID: 38398781 Free PMC article. Review.
-
Loss of flavin-containing monooxygenase 3 modulates dioxin-like polychlorinated biphenyl 126-induced oxidative stress and hepatotoxicity.Environ Res. 2024 Jun 1;250:118492. doi: 10.1016/j.envres.2024.118492. Epub 2024 Feb 17. Environ Res. 2024. PMID: 38373550
-
Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma.iScience. 2023 Oct 30;26(12):108363. doi: 10.1016/j.isci.2023.108363. eCollection 2023 Dec 15. iScience. 2023. PMID: 38034347 Free PMC article. Review.
-
Association between dietary intakes of B vitamins and nonalcoholic fatty liver disease in postmenopausal women: a cross-sectional study.Front Nutr. 2023 Oct 19;10:1272321. doi: 10.3389/fnut.2023.1272321. eCollection 2023. Front Nutr. 2023. PMID: 37927496 Free PMC article.
-
Dietary choline intake and non-alcoholic fatty liver disease (NAFLD) in U.S. adults: National Health and Nutrition Examination Survey (NHANES) 2017-2018.Eur J Clin Nutr. 2023 Dec;77(12):1160-1166. doi: 10.1038/s41430-023-01336-1. Epub 2023 Aug 26. Eur J Clin Nutr. 2023. PMID: 37634048
References
-
- Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004;40:1387–95 - PubMed
-
- Kim WR, Brown RS, Jr, Terrault NA, El-Serag H. Burden of liver disease in the United States: summary of a workshop. Hepatology 2002;36:227–42 - PubMed
-
- Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 2001;21:17–26 - PubMed
-
- Chitturi S, Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 2001;21:27–41 - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
- U01DK061713/DK/NIDDK NIH HHS/United States
- U01 DK061732/DK/NIDDK NIH HHS/United States
- U01DK061731/DK/NIDDK NIH HHS/United States
- U01DK061737/DK/NIDDK NIH HHS/United States
- U01DK061718/DK/NIDDK NIH HHS/United States
- U01DK061732/DK/NIDDK NIH HHS/United States
- U01DK061728/DK/NIDDK NIH HHS/United States
- U01 DK061730/DK/NIDDK NIH HHS/United States
- U01 DK061728/DK/NIDDK NIH HHS/United States
- UL1 TR000454/TR/NCATS NIH HHS/United States
- U01DK061738/DK/NIDDK NIH HHS/United States
- U01DK061734/DK/NIDDK NIH HHS/United States
- U01DK061730/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous